Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustained virological response (SVR) reduces even more the risk. Presentation of case Liver resection for small HCC was performed in cleared HCV infection non-cirrhotic 62-year-old man. Methacronous oligometastatic recurrences in intolerant to Nexavar® side-effects patient, were treated by multiple innovative microinvasive approaches: bilateral laparoscopic adrenalectomy, thoracic wall resection, laparoscopic sacrum cryoablation combined with hadron-therapy. Discussion Therapies allowed the patient to lead 6 years satisfying QoL with only a small residual presacral disease stable at 8 months. Conclusion Microinvasive surgery may be a valid resource of therapy in indolent HCC limited distant recurrences.
Case-report. Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver. Surgical therapy / Brozzetti, Stefania; Bini, Simone; Fazzi, Katia; Chiarella, Leonardo Luca; Ceccarossi, Virginia; De Lucia, Chiara; De Toma, Giorgio. - In: INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. - ISSN 2210-2612. - 47:(2018), pp. 19-21. [10.1016/j.ijscr.2018.04.013]
Case-report. Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver. Surgical therapy
Brozzetti, Stefania
;Bini, Simone;Fazzi, Katia;Chiarella, Leonardo Luca;Ceccarossi, Virginia;De Lucia, Chiara;De Toma, Giorgio
2018
Abstract
Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustained virological response (SVR) reduces even more the risk. Presentation of case Liver resection for small HCC was performed in cleared HCV infection non-cirrhotic 62-year-old man. Methacronous oligometastatic recurrences in intolerant to Nexavar® side-effects patient, were treated by multiple innovative microinvasive approaches: bilateral laparoscopic adrenalectomy, thoracic wall resection, laparoscopic sacrum cryoablation combined with hadron-therapy. Discussion Therapies allowed the patient to lead 6 years satisfying QoL with only a small residual presacral disease stable at 8 months. Conclusion Microinvasive surgery may be a valid resource of therapy in indolent HCC limited distant recurrences.File | Dimensione | Formato | |
---|---|---|---|
Brozzetti_Metastases-HCC_2018.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
642.26 kB
Formato
Adobe PDF
|
642.26 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.